Lv6
1970 积分 2024-08-14 加入
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
1个月前
已完结
Recent advances in tropomysosin receptor kinase (TRK) inhibitors: a 2023–2024 patent landscape review
2个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
2个月前
已完结
Protein Kinases – High Yield Targets for Cancer and Dementia Drug Discovery
2个月前
已完结
Routine molecular profiling of patients with NSCLC
2个月前
已完结
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program
2个月前
已关闭
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
3个月前
已完结
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
3个月前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
3个月前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
3个月前
已完结
皖公网安备34019202002308
